Successful scale-up and BLA filings for products manufactured by microbial biomanufacturing require strategic planning.
Stéphane Varray
Advertisement
Stéphane Varray, PhD, is senior director, head of Commercial Development, Microbial Business Unit, at Lonza.
Articles by Stéphane Varray
Advertisement
Latest Updated Articles
Outlining Successful Steps for Scale-Up and BLA FilingsPublished: August 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
2
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
3
Pharma Tariff FAQ: Costs, Supply Chains, Policy for 2025
4
Scaling Manufacturing of Novel Therapies
5
